VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,208,000 | +94.3% | 137,906 | +32.8% | 0.01% | +100.0% |
Q1 2018 | $1,651,000 | -29.7% | 103,806 | -7.6% | 0.00% | -25.0% |
Q4 2017 | $2,348,000 | +297.3% | 112,306 | +171.9% | 0.00% | +300.0% |
Q3 2017 | $591,000 | -98.4% | 41,306 | -98.0% | 0.00% | -98.8% |
Q2 2017 | $36,525,000 | +39174.2% | 2,104,500 | +24953.6% | 0.08% | – |
Q1 2017 | $93,000 | – | 8,400 | +83900.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 10 | -99.8% | 0.00% | – |
Q3 2016 | $115,000 | -87.4% | 4,710 | -89.7% | 0.00% | -100.0% |
Q2 2016 | $913,000 | -3.4% | 45,510 | +26.7% | 0.00% | 0.0% |
Q1 2016 | $945,000 | -91.3% | 35,910 | -67.1% | 0.00% | -92.2% |
Q4 2015 | $10,914,000 | -92.3% | 109,072 | -86.3% | 0.05% | -91.2% |
Q3 2015 | $141,153,000 | -8.2% | 794,472 | +14.8% | 0.58% | +15.5% |
Q2 2015 | $153,770,000 | -0.6% | 691,872 | -11.6% | 0.50% | -12.2% |
Q1 2015 | $154,636,000 | +30.9% | 782,727 | -4.8% | 0.57% | +50.9% |
Q4 2014 | $118,104,000 | +41.3% | 822,427 | +29.2% | 0.38% | +29.4% |
Q3 2014 | $83,572,000 | +6.8% | 636,427 | +3.0% | 0.29% | +8.1% |
Q2 2014 | $78,247,000 | +4.3% | 617,644 | +8.4% | 0.27% | -9.1% |
Q1 2014 | $75,053,000 | +96.4% | 569,579 | +74.8% | 0.30% | +92.3% |
Q4 2013 | $38,208,000 | -70.6% | 325,761 | -73.8% | 0.16% | -73.4% |
Q3 2013 | $130,145,000 | +839.1% | 1,245,591 | +672.6% | 0.58% | +743.5% |
Q2 2013 | $13,859,000 | -17.2% | 161,230 | -27.7% | 0.07% | -20.7% |
Q1 2013 | $16,733,000 | – | 222,917 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |